ArticleOpen forum infectious diseases2022

CNS TB-IRIS Following Cessation of Adalimumab in an Adolescent With Crohn's Disease.

Elizabeth Christian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.